The functional gamma-secretase inhibitor prevents production of amyloid beta 1-34 in human and murine cell lines (Q40767327)

23 September 2017

The functional gamma-secretase inhibitor prevents production of amyloid beta 1-34 in human and murine cell lines (English)

1 reference

23 September 2017

Vandermeeren M

1

1 reference

23 September 2017

Geraerts M

2

1 reference

23 September 2017

Pype S

3

1 reference

23 September 2017

Dillen L

4

1 reference

23 September 2017

Van Hove C

5

1 reference

23 September 2017

Mercken M

6

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

23 September 2017

4

1 reference

inferred from page(s)

published in

Neuroscience Letters

1 reference

23 September 2017

315

1 reference

23 September 2017

145-148

1 reference

23 September 2017

3

1 reference

BACE1 is the major beta-secretase for generation of Abeta peptides by neurons

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902369-2

7 January 2021

Processing of beta-secretase by furin and other members of the proprotein convertase family

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902369-2

7 January 2021

Image analysis of beta-amyloid load in Alzheimer's disease and relation to dementia severity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902369-2

7 January 2021

Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902369-2

7 January 2021

Degradation of the Alzheimer's amyloid beta peptide by endothelin-converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902369-2

7 January 2021

Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902369-2

7 January 2021

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902369-2

7 January 2021

Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902369-2

7 January 2021

Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902369-2

7 January 2021

Amino- and carboxyl-terminal heterogeneity of beta-amyloid peptides deposited in human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902369-2

7 January 2021

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902369-2

7 January 2021

Purification and cloning of amyloid precursor protein beta-secretase from human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902369-2

7 January 2021

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902369-2

7 January 2021

The profile of soluble amyloid beta protein in cultured cell media. Detection and quantification of amyloid beta protein and variants by immunoprecipitation-mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902369-2

7 January 2021

10.1016/S0304-3940(01)02369-2

Identifiers

DOI

1 reference

23 September 2017

1 reference